Industry Reports & Infographics

Find objective supply chain related reports, infographics and up-to-date pharma logistics information. 

227 whitepaper results
of 23

Essentra provides end-to-end healthcare packaging and security solutions for brands and consumer throughout the world in pharmaceuticals, life sciences and medical devices. Learn more

Essentra works with the healthcare industry to offer a combination of cutting-edge technology, a rigorous code of conduct and more than 30 years’ security experience that protects their brands. Learn more

To meet the new guidelines of the Falsified Medicines Directive published by the European Parliament Council, Essentra has launched a new range of high quality labelling solutions Learn more

How do you shift through the phases of product development and production in pharmaceutical packaging using Essentra’s Design Hub to create aesthetically-pleasing packaging that is easy-to-use, environmentally conscious, and brand enhancing. Learn more

This 2017 report provides a snapshot of the industry’s status as it stands today and gives valuable insights on: Packaging and Labelling Regulatory Compliance, Artwork Management, New Technologies Trends, Patient Compliance and Tamper Evident Packaging Features. Learn more

The global pharma market faces unprecedented complexities and pressures regarding the packaging and labelling of medicinal products. Ahead of the 2017 Packaging and Labelling Summit, this guide examines the changes required for pharmaceutical packaging to meet the requirements of EU Falsified Medicines Directive (FMD) and the crucial questions to ask in order to achieve compliance. Learn more

Tags:

The anti-tampering market is littered with challenges to address: meeting EU FMD requirements, satisfying country specific requirements, preserving patient usability and not to mention outwitting resourceful counterfeiters. Ahead of the packaging and labelling summit in June Pharma IQ explores the world of tamper evidence in pharma packaging Learn more

Tags:

Pharma IQ examines the opportunities available when maximizing the ROI of serialization and traceability systems beyond compliance. Learn more

Ahead of the traceability in operation forum 2017 Pharma IQ conducted some market research to pinpoint the concerns and priorities of those in the more mature phases of serialisation. Commentary supplied by Pasi Kemppainen, Executive Consultant, Pharma Serialization and Traceability. Learn more

Many will argue that the accountability of ensuring product safety and integrity lies with the manufacturer from production to the end point of the supply chain. After all, it is their name on the label. But if that is the case, then where does the responsibility lie once a product changes hands? Learn more

Tags:
227 whitepaper results
of 23